FOCUSED ON WOMEN'S HEALTH
and hormone-sensitive cancer for healthy aging worldwide
Our solution
A low dose (6.5 mg) of intravaginal DHEA permits a local action while maintaining serum estrogens or androgens as well as their metabolites within normal values.
Our main goal is to offer all women in the world, in addition to the treatment of vaginal atrophy, the benefits of effective, physiological and non-negative treatments for all menopausal problems, including hot flashes, bone loss and muscle loss.
